Cited 0 time in
Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Heemoon | - |
| dc.contributor.author | Jo, Soo Min | - |
| dc.contributor.author | Jin, Kwang Nam | - |
| dc.contributor.author | Lee, Hyo Jin | - |
| dc.contributor.author | Lee, Hyun Woo | - |
| dc.contributor.author | Park, Tae Yun | - |
| dc.contributor.author | Heo, Eun Young | - |
| dc.contributor.author | Kim, Deog Kyeom | - |
| dc.contributor.author | Lee, Jung-Kyu | - |
| dc.date.accessioned | 2025-04-15T00:30:15Z | - |
| dc.date.available | 2025-04-15T00:30:15Z | - |
| dc.date.issued | 2025-03 | - |
| dc.identifier.issn | 1471-2466 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/58210 | - |
| dc.description.abstract | BackgroundChronic obstructive pulmonary disease (COPD) can occur in patients without a history of smoking, which is a strong risk factor for COPD. However, few studies have focused on the prognosis of never-smokers with COPD. We investigated the difference of the longitudinal clinical outcomes between never-smokers and ever-smokers with COPD.MethodsWe retrospectively analyzed patients with COPD who underwent chest computed tomography and longitudinal lung function tests from January 2013 to December 2020. We classified patients according to smoking status and examined their histories of acute exacerbation and long-term changes in lung function.ResultsAmong 583 patients with COPD, 75 (12.9%) had no smoking history. These never-smokers with COPD were predominantly women; they had a lower forced vital capacity and a higher prevalence of asthma, history of tuberculosis, tuberculosis-destroyed lung, and bronchiectasis, but a lower prevalence of emphysema, relative to ever-smokers with COPD. Never-smokers with COPD had significantly lower risks of subsequent moderate to severe exacerbation (beta +/- standard error, - 0.4 +/- 0.12; P = 0.001), any exacerbation (adjusted odds ratio, 0.46; 95% confidence interval, 0.26 - 0.8; P = 0.006), and frequent exacerbation (adjusted odds ratio, 0.28; 95% confidence interval, 0.09 - 0.89; P = 0.03) than ever-smokers with COPD. Never-smokers with COPD also showed significantly slower annual decline of forced expiratory volume in 1 s than ever-smokers with COPD (- 15.7 +/- 4.7 vs. -30.4 +/- 2.9 mL, respectively; P = 0.03).ConclusionsNever-smokers with COPD had significantly fewer acute exacerbations and slower decline of lung function than ever-smokers with COPD during longitudinal follow-up. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BioMed Central Ltd | - |
| dc.title | Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1186/s12890-025-03604-1 | - |
| dc.identifier.scopusid | 2-s2.0-105001246481 | - |
| dc.identifier.wosid | 001455996700002 | - |
| dc.identifier.bibliographicCitation | BMC Pulmonary Medicine, v.25, no.1 | - |
| dc.citation.title | BMC Pulmonary Medicine | - |
| dc.citation.volume | 25 | - |
| dc.citation.number | 1 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Respiratory System | - |
| dc.relation.journalWebOfScienceCategory | Respiratory System | - |
| dc.subject.keywordPlus | OBSTRUCTIVE PULMONARY-DISEASE | - |
| dc.subject.keywordPlus | POPULATION | - |
| dc.subject.keywordAuthor | COPD | - |
| dc.subject.keywordAuthor | Never-smoker | - |
| dc.subject.keywordAuthor | Exacerbation | - |
| dc.subject.keywordAuthor | Lung function | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
